Long-term immunosuppressive therapy of ulcerative colitis. Continuation of a personal series.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003093:Colitis, Ulcerative / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011859:Radiography; D012008:Recurrence; D012460:Sulfasalazine / Q000627:therapeutic use; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D012460:Sulfasalazine; D000324:Adrenocorticotropic Hormone; D015122:Mercaptopurine; D011241:Prednisone